Regulus Therapeutics(RGLS)

超过5%股东持股披露「修订」

Regulus Therapeutics(RGLS)03-19 09:15

$Regulus Therapeutics(RGLS)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000344  Act: 34  Size: 422 KB 网页链接查看全文

股东委托书协议

Regulus Therapeutics(RGLS)04-20 04:15

$Regulus Therapeutics(RGLS)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-102883  Act: 34  Size: 1 MB 网页链接查看全文

持股变动声明

Regulus Therapeutics(RGLS)03-16 04:25

$Regulus Therapeutics(RGLS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-032213  Size: 4 KB 网页链接查看全文

当期报告

Regulus Therapeutics(RGLS)03-22 04:25

$Regulus Therapeutics(RGLS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-073858  Act: 34  Size: 203 KB 网页链接查看全文

超过5%股东持股披露

Regulus Therapeutics(RGLS)03-21 04:35

$Regulus Therapeutics(RGLS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-024390  Act: 34  Size: 75 KB 网页链接查看全文

生效批准

Regulus Therapeutics(RGLS)04-22 18:05

$Regulus Therapeutics(RGLS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001050  Act: 33  Size: 1 KB 网页链接查看全文

超过5%股东持股披露「修订」

Regulus Therapeutics(RGLS)02-07 00:15

$Regulus Therapeutics(RGLS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001040188-24-000018  Act: 34  Size: 43 KB 网页链接查看全文

超过5%股东持股披露

Regulus Therapeutics(RGLS)02-15 03:55

$Regulus Therapeutics(RGLS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001389932-24-000008  Act: 34  Size: 11 KB 网页链接查看全文

超过5%股东持股披露「修订」

Regulus Therapeutics(RGLS)04-10 22:15

$Regulus Therapeutics(RGLS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001710  Act: 34  Size: 8 KB 网页链接查看全文

其他

Regulus Therapeutics(RGLS)04-20 04:15

$Regulus Therapeutics(RGLS)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102892  Act: 34  Size: 1 MB 网页链接查看全文

Dinx2022-05-12 01:27

$Regulus Therapeutics(RGLS)$ h查看全文

hahababachn2021-12-08 15:00

$Regulus Therapeutics(RGLS)$ 纳入关注查看全文

chuminhua2021-10-14 11:55

10月13日，Regulus Therapeutics公司再次对其管线进行了调整，并将一个新的肾脏疾病候选药物放入高优先级的队列中，希望在经历了一连串的失败和优先级的改变后能有更好的运气。
这家生物技术公司宣布，RGLS8429将成为其新的肾脏疾病候选药物，取代类似的用于常染色体显性多囊肾病（ADPKD）的RG...查看全文

寂寞的搬运工2021-04-17 00:21

$Regulus Therapeutics(RGLS)$ 后半夜反转查看全文

寂寞的搬运工2021-03-21 13:07

$Regulus Therapeutics(RGLS)$ 月线图显示横盘4年，底部放量，看能不能涨4倍查看全文

群氓鄙陋2020-07-29 22:45

请问 $Regulus Therapeutics(RGLS)$ 这家公司干什么的？有何值得关注的？查看全文

兔斯基不吃面2020-07-29 22:43

$Regulus Therapeutics(RGLS)$ 床单被套了补点货降低成本，毕竟这么便宜😅查看全文

兔斯基不吃面2020-07-29 22:35

$Regulus Therapeutics(RGLS)$ 量能和换手率在这，下一个高点应该是向3.14$进军，1.74$就是纸糊的查看全文

无记名人氏2020-07-29 22:11

$Regulus Therapeutics(RGLS)$ 卡在+50% 1.2的位置重新突破高点就好了查看全文

兔斯基不吃面2020-07-29 22:00

$Regulus Therapeutics(RGLS)$ 前期高点1.74$今夜放量突破查看全文

生效批准

$Regulus Therapeutics(RGLS)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-004653  Act: 33  Size: 1 KB 网页链接

超过5%股东持股披露「修订」

$Regulus Therapeutics(RGLS)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-21-000667  Act: 34  Size: 447 KB 网页链接

发行公告

$Regulus Therapeutics(RGLS)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001724792-21-000001  Act: 33  Size: 19 KB 网页链接

招股说明书

$Regulus Therapeutics(RGLS)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001193125-21-346867  Act: 33  Size: 251 KB 网页链接

持股变动声明

$Regulus Therapeutics(RGLS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-067264  Size: 4 KB 网页链接

当期报告

$Regulus Therapeutics(RGLS)$ 8-K Current report, items 5.03, 8.01, and 9.01 Accession Number: 0001193125-21-343820  Act: 34  Size: 520 KB 网页链接

员工持股计划

$Regulus Therapeutics(RGLS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-21-342440  Act: 33  Size: 257 KB 网页链接

当期报告

$Regulus Therapeutics(RGLS)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001193125-21-340437  Act: 34  Size: 168 KB 网页链接

季度财报

$Regulus Therapeutics(RGLS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-21-022902  Act: 34  Size: 6 MB 网页链接

当期报告

$Regulus Therapeutics(RGLS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-21-326088  Act: 34  Size: 205 KB 网页链接